- Date of occurrence: October 6, 2017
- Company name: OBI Pharma Inc.
- Relationship to the Company (please enter ”head office” or ”affiliated company”): head office
- Reciprocal shareholding ratios: N/A
- Cause of occurrence: USPTO Granted OBI-888’s patent application on “Antibodies, pharmaceutical compositions and uses thereof” (Application No. 15 / 303,132)
- Countermeasures: None
- Any other matters that need to be specified: None
